Biotech Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement for Moderna to acquire OriCiro at a cost of $85 million.

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments.

Stay up-to-date on Moderna, Inc. Common Stock (MRNA) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.

Ziarul Evenimentul Cotidian Regional al Moldovei. Citeşte zilnic ultimele ştiri şi anunţuri din Moldova: Iaşi - Bacău - Botoşani - Neamţ - Suceava - Vaslui ...